← Back to charts
GLP-1 Tracker: Ozempic, Wegovy icon
GOOGLE PLAY

GLP-1 Tracker: Ozempic, Wegovy

Wiserapps Software · Health & Fitness · Brazil store
NOT IN TOP 100 HERE
View on Google Play ↗ Instagram card App Store version →
Revenue a month, worldwide EST
$578
Likely $193 to $1.7K
New ratings
Tracking
Daily counts start building from today
Rating
4.9 of 5
497 ratings in this store
Countries it ranks in
0
was 0 on Oct 19, 2026

Revenue

Estimated from the grossing charts of Oct 25, 2026 in the 53 countries we track, and ratings growth on the App Store.

EST. REVENUE / YEAR · WORLDWIDE
$6.9K
5.5 new ratings a month on average since launch
LIFETIME INSTALLS (GOOGLE)
6.4K
About 1.1K per month on average since launch
WHERE ITS USERS ARE · SHARE OF RATINGS
  • Brazil 8 ratings26%
  • Germany 5 ratings16%
  • Turkey 5 ratings16%
  • Saudi Arabia 4 ratings13%
  • United States 2 ratings6%
  • France 2 ratings6%
  • Spain 2 ratings6%
  • United Kingdom 1 ratings3%
HOW SURE ARE WE
Not in any grossing chart, so this comes from ratings growth (5.5 new ratings a month on average since launch): revenue grows with new ratings, more slowly for apps that collect ratings fast. Tested on 418 apps with verified revenue: typically off by about 2 times, and big earners tend to come out low. Countries we don't track (and Google Play in China, which doesn't exist) aren't included, and neither are ads or web payments. Gross revenue before store fees.
RATINGS
497
AVG RATING
4.86
PRICE
Free
IN APP PURCHASES
R$19.99 - R$99.99 per item
CONTAINS ADS
No
LAST UPDATE
11d ago
RELEASED
Apr 29, 2026
CONTENT RATING
All ages

Last 30 days

From our daily snapshots of every grossing chart.

DAYS IN A GROSSING CHART
0 / 30
COUNTRIES NOW
0 (was 0)
EST. REVENUE FROM CHARTS, DAILY · BOTH STORES ONLY EST
Show daily values
Sep 27, 2026not in a grossing chart
Sep 28, 2026not in a grossing chart
Sep 29, 2026not in a grossing chart
Sep 30, 2026not in a grossing chart
Oct 1, 2026not in a grossing chart
Oct 2, 2026not in a grossing chart
Oct 3, 2026not in a grossing chart
Oct 4, 2026not in a grossing chart
Oct 5, 2026not in a grossing chart
Oct 6, 2026not in a grossing chart
Oct 7, 2026not in a grossing chart
Oct 8, 2026not in a grossing chart
Oct 9, 2026not in a grossing chart
Oct 10, 2026not in a grossing chart
Oct 11, 2026not in a grossing chart
Oct 12, 2026not in a grossing chart
Oct 13, 2026not in a grossing chart
Oct 14, 2026not in a grossing chart
Oct 15, 2026not in a grossing chart
Oct 16, 2026not in a grossing chart
Oct 17, 2026not in a grossing chart
Oct 18, 2026not in a grossing chart
Oct 19, 2026not in a grossing chart
Oct 20, 2026not in a grossing chart
Oct 21, 2026not in a grossing chart
Oct 22, 2026not in a grossing chart
Oct 23, 2026not in a grossing chart
Oct 24, 2026not in a grossing chart
Oct 25, 2026not in a grossing chart
Oct 26, 2026not in a grossing chart
Best rank Sep 27, 2026: not ranked. Now: not ranked. Days at zero are days outside every grossing chart.

Money and momentum

Measured from the store, not estimated.

WHAT IT CHARGES
R$19.99 - R$99.99 per item
Google Play only shows the price range per item.
REVIEW MOMENTUM
0.3 reviews / week
  • Recent reviews average3.5 stars
  • Recent 1 and 2 star share25%
From the latest 4 written reviews, covering 109 days.
RATING BREAKDOWN
495 ratings
5★91%
4★4%
3★4%
2★0%
1★0%

What users say

Latest reviews, Brazil Google Play.

★★★★★Sep 19, 2026

it's not for Free. disappointed ☹️

★★★★★Sep 9, 2026

let's take our health seriously

★★★★★Aug 20, 2026

the widget doesn't work

★★★★★Jul 9, 2026

logging in was easy

Store screenshots

ScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshot

App Store ads

Apple Search Ads this app ran in the last 90 days, from Apple's public ad repository.

STATUS
Stopped
FIRST SEEN
Jun 14, 2026
AD VARIATIONS
91
EU COUNTRIES
12
WHERE
Search results in AT, BE, DE, ES, FI, FR, GR, HR, IT, NL, PT, SE. Formats: Icon + Asset Ad, Icon Ad. Last impression Oct 20, 2026.
AD TEXT
  • Mounjaro, Wegovy & Ozempic Log
  • Ozempic, Wegovy & Mounjaro Log
  • Dose Ozempic, Wegovy, Mounjaro
  • Ozempic, Wegovy e Mounjaro
  • Ozempic & Wegovy & Mounjaro
  • Ozempic, Wegovy y Mounjaro
Ad creativeAd creativeAd creativeAd creativeAd creativeAd creative

Apple only publishes ads shown in the EU (EU Digital Services Act), with a 7 day delay. An app that advertises only outside the EU shows nothing here. Shown for the App Store version (GLP-1 Tracker: Abnehmspritze).

Growth research

Where this app is buying and earning its users. Each link opens pre filtered.

ASO keywords

Most repeated terms in the listing. Highlighted ones also appear in the title or short description.

glp8glp tracker8tracker5weight5ozempic wegovy5mounjaro zepbound5log4home screen3wegovy rybelsus3registered trademarks3novo nordisk3eli lilly3wiserapps glp3ozempic3wegovy3mounjaro3zepbound3rybelsus3dose3meals3journal3private2saxenda2track2

What's new in 2.2.0

• Weekly recap with personal insights and a Monday reminder • Week-by-week history and symptoms across your dose week • Injection site map: see which spot has rested longest • Fat tracking • Doctor visit prep: appointment reminder and a PDF summary with your questions • Pro: log meals by typing or scanning a barcode • Bug fixes and stability improvements

Store description

Your GLP-1 companion — in one private, elegant app. GLP-1 Tracker helps you stay consistent on your Ozempic®, Wegovy®, Mounjaro®, Zepbound®, Saxenda® or Rybelsus® journey. Log every dose, track side effects, record meals and watch your weight trend — all in one calm, focused space. WHAT YOU CAN DO • Dose tracking — Log injections or oral doses, rotate injection sites, and get weekly reminders so you never miss a shot. • Weight & progress — Track weight, BMI, waist and body measurements with beautiful charts. • Side-effect journal — Note nausea, fatigue, reflux, headaches and more. Spot patterns and share with your clinician. • Smart food log — Search a clean food database and see calories, macros, glycemic index (GI) and glycemic load (GL) at a glance. Perfect for GLP-1 users focused on protein and low-GI meals. • Curated recipes — Low-GI, high-protein ideas for every meal. • Lifestyle — Water, steps, sleep and daily goals that support your shot and your body. • Calendar & journal — A unified daily log for doses, meals, symptoms, weight and mood. • Home-screen widget — Your next dose and today's progress, right on your home screen. • Export — Share clean PDF reports with your doctor or dietitian. • Private by default — Your data stays on your device. No account required. WHO IT'S FOR Anyone using or planning to start a GLP-1 medication — semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound) or liraglutide (Saxenda, Victoza). Whether you're on a weight-loss plan, managing type 2 diabetes with your clinician, or simply want a clearer picture of how the medication is affecting you — GLP-1 Tracker is built for you. PREMIUM The free version lets you try the essentials. Upgrade to Premium for unlimited logs, advanced charts and PDF export. IMPORTANT GLP-1 Tracker is a personal wellness journal. It does not provide medical advice, diagnosis or treatment. Always follow the instructions of your licensed healthcare provider. Ozempic®, Wegovy® and Rybelsus® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. This app is not affiliated with or endorsed by Novo Nordisk or Eli Lilly. Terms of use: https://www.wiserapps.co/glp-tracker-terms-conditions Privacy policy: https://www.wiserapps.co/glp-tracker-privacy-policy

See this store page in another country

Prices, ranks and reviews are per country. Revenue above is already worldwide.

More from Wiserapps Software

English Vocabulary Builder
Analyze →
Heart Rate Monitor - BP Log
4.2 ★
Analyze →
Glycemic Index Guide: Diabetes
4.8 ★
Analyze →
Tattoo IA – Design & Gerador
Analyze →
Interior AI - Home Design AI
3.7 ★
Analyze →
Homework AI - Scan Math Helper
Analyze →
Pregnancy Diet: Recipes, Foods
4.4 ★
Analyze →
Start Solids & Baby Recipes
4.8 ★
Analyze →
KPSS Güncel Bilgiler
Analyze →